Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab-论文-万方医学网

首页> > Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab

Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab

导出原文传递

翻译打印收藏纠错

第一作者： Kulasekararaj, Austin G.

作者： Kulasekararaj, Austin G. ^[1] ; Risitano, Antonio M. ^[2] ; Maciejewski, Jaroslaw P. ^[3] ; Notaro, Rosario ^[4] ; Browett, Peter ^[5] ; Lee, Jong Wook ^[6] ; Huang, Mingjun ^[7] ; Geffner, Michael ^[8] ; Brodsky, Robert A.

作者单位： Federico II Univ Naples ^[1] Azienda Osped,Univ Careggi ^[2] Dept Translat Hematol & Oncol Res,Cleveland Clin ^[3] Seoul St Marys Hosp,Catholic Univ Korea ^[4] Univ Auckland ^[5] Achillion Inc,Wholly Owned Subsidiary Alexion Pharmaceut Inc ^[6] NIHR Wellcome Kings Clin Res Facil,Kings Coll Hosp NHS Fdn Trust ^[7] Sch Med,Johns Hopkins Univ ^[8]

关键词 COMPLEMENT INHIBITOR ECULIZUMAB EXTRAVASCULAR HEMOLYSIS ALTERNATIVE PATHWAY ERYTHROCYTES MECHANISM PROTEIN DISEASE LYSIS

发布时间 2022-04-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab

相似文献

同项目论文

相关期刊

检索历史 清除

Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab

相似文献

同项目论文

相关期刊

检索历史清除